OpenAlex
PricingAboutJobs
Log inGet started
Work

Targeting the RB-E2F pathway in breast cancer

HTML

Year: 2016
Type: review
Source: Oncogene
DOI: 10.1038/onc.2016.32
Authors: J Johnson, B Thijssen, U McDermott, M Garnett, L F A Wessels, R Bernards
Institutions: The Netherlands Cancer Institute, Wellcome Sanger Institute
Language: English

Topic: Advanced Breast Cancer Therapies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: Rb/E2F pathway, retinoblastoma protein, breast cancer, CDK4/6 inhibitors, palbociclib, estrogen receptor-positive breast cancer, E2F transcription factors, synthetic lethality, combination therapy, tumor progression, angiogenesis, metastasis, prognostic factors, cell cycle regulation
SDG: Good health and well-being

Open Access status: green

Funder: Wellcome Trust
Awards: G4167507723, Cominatorial therapeutics to target the cancer geneome.
OpenAlex ID: W2291124025
FWCI: 2.475
Cites: 66
Cited by: 222
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security